B. Frieberg - Oct 23, 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Jacob B. Frieberg
Stock symbol
VCNX
Transactions as of
Oct 23, 2023
Transactions value $
-$8,694
Form type
4
Date filed
10/25/2023, 04:30 PM
Previous filing
Oct 5, 2023
Next filing
May 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding VCNX Common Stock 4.24K Oct 23, 2023 Direct
holding VCNX Common Stock 6.3K Oct 23, 2023 By Benbow Estates, Ltd. F1
holding VCNX Common Stock 12.9K Oct 23, 2023 By Gee Eff Services Limited F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Disposed to Issuer -$8.69K -11.3K -100% $0.77 0 Oct 23, 2023 Common Stock 11.3K $1.13 Direct F9
holding VCNX Stock Option (Right to Buy) 426 Oct 23, 2023 Common Stock 426 $204.00 Direct F3
holding VCNX Stock Option (Right to Buy) 166 Oct 23, 2023 Common Stock 166 $78.90 Direct F3
holding VCNX Stock Option (Right to Buy) 514 Oct 23, 2023 Common Stock 514 $116.70 Direct F3, F4
holding VCNX Stock Option (Right to Buy) 159 Oct 23, 2023 Common Stock 159 $82.80 Direct F3
holding VCNX Stock Option (Right to Buy) 123 Oct 23, 2023 Common Stock 123 $107.55 Direct F3
holding VCNX Stock Option (Right to Buy) 182 Oct 23, 2023 Common Stock 182 $72.75 Direct F3
holding VCNX Stock Option (Right to Buy) 222 Oct 23, 2023 Common Stock 222 $60.00 Direct F3
holding VCNX Stock Option (Right to Buy) 1.05K Oct 23, 2023 Common Stock 1.05K $59.25 Direct F3, F5
holding VCNX Stock Option (Right to Buy) 250 Oct 23, 2023 Common Stock 250 $54.15 Direct F3
holding VCNX Stock Option (Right to Buy) 508 Oct 23, 2023 Common Stock 508 $26.70 Direct F3
holding VCNX Stock Option (Right to Buy) 436 Oct 23, 2023 Common Stock 436 $31.05 Direct F3
holding VCNX Stock Option (Right to Buy) 302 Oct 23, 2023 Common Stock 302 $44.70 Direct F3
holding VCNX Stock Option (Right to Buy) 1.91K Oct 23, 2023 Common Stock 1.91K $32.25 Direct F3, F6
holding VCNX Stock Option (Right to Buy) 320 Oct 23, 2023 Common Stock 320 $42.00 Direct F3
holding VCNX Stock Option (Right to Buy) 415 Oct 23, 2023 Common Stock 415 $32.40 Direct F3
holding VCNX Stock Option (Right to Buy) 857 Oct 23, 2023 Common Stock 857 $15.60 Direct F3
holding VCNX Stock Option (Right to Buy) 668 Oct 23, 2023 Common Stock 668 $19.80 Direct F3
holding VCNX Stock Option (Right to Buy) 3.55K Oct 23, 2023 Common Stock 3.55K $16.80 Direct F3, F7
holding VCNX Stock Option (Right to Buy) 804 Oct 23, 2023 Common Stock 804 $16.20 Direct F3
holding VCNX Stock Option (Right to Buy) 1.75K Oct 23, 2023 Common Stock 1.75K $7.43 Direct F3
holding VCNX Stock Option (Right to Buy) 1.32K Oct 23, 2023 Common Stock 1.32K $9.68 Direct F3
holding VCNX Stock Option (Right to Buy) 2.14K Oct 23, 2023 Common Stock 2.14K $5.99 Direct F3
holding VCNX Stock Option (Right to Buy) 9.59K Oct 23, 2023 Common Stock 9.59K $6.15 Direct F8
holding VCNX Stock Option (Right to Buy) 2.41K Oct 23, 2023 Common Stock 2.41K $5.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Mr. Frieberg's spouse is the owner of Benbow Estates, Ltd. and Mr. Frieberg is an officer of Benbow Estates, Ltd. Mr. Frieberg disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F2 Mr. Frieberg is the sole owner and President of Gee Eff Services Limited.
F3 Exercisable in full as of the date of this report.
F4 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F5 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F6 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F7 This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
F8 This option expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.
F9 This option was canceled by mutual agreement of the reporting person and Vaccinex, Inc. The reporting person received $8,750 as consideration for the cancellation, which represents the reporting person's retainer and meeting fees during the third quarter of 2023.

Remarks:

On September 25, 2023, Vaccinex, Inc. effected a 1-for-15 reverse stock split (the "Reverse Stock Split"). The number of stock options and underlying shares of common stock in this Form 4 reflect the Reverse Stock Split.